Literature DB >> 2914841

Long-term efficacy of haloperidol in autistic children: continuous versus discontinuous drug administration.

R Perry, M Campbell, P Adams, N Lynch, E K Spencer, E L Curren, J E Overall.   

Abstract

The aim of this study was to evaluate the long-term efficacy of haloperidol in autistic children and to determine whether discontinuous drug administration was as effective as continuous drug administration. Sixty children, 48 males and 12 females, ages 2.3 to 7.9 years (X 5.1) completed the study. They received haloperidol over a period of 6 months followed by a 4-week drug withdrawal/placebo period. Haloperidol remained effective, and the discontinuous treatment schedule did not diminish its efficacy. Children with prominent symptoms of irritability, angry and labile affect, and uncooperativeness were the best responders to haloperidol.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2914841     DOI: 10.1097/00004583-198901000-00016

Source DB:  PubMed          Journal:  J Am Acad Child Adolesc Psychiatry        ISSN: 0890-8567            Impact factor:   8.829


  24 in total

Review 1.  Typical neuroleptics in child and adolescent psychiatry.

Authors:  C Gillberg
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

Review 2.  Autism: current theories regarding its pathogenesis and implications for rational pharmacotherapy.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

3.  Efficacy of duloxetine and agomelatine does not exceed that of other antidepressants in patients with autistic disorder: preliminary results in 3 patients.

Authors:  Helmut Niederhofer
Journal:  Prim Care Companion CNS Disord       Date:  2011

4.  Pharmacological therapies for autism spectrum disorder: a review.

Authors:  Sheena LeClerc; Deidra Easley
Journal:  P T       Date:  2015-06

5.  Treatment of Autism Spectrum Disorder in Children and Adolescents.

Authors:  Melissa DeFilippis; Karen Dineen Wagner
Journal:  Psychopharmacol Bull       Date:  2016-08-15

Review 6.  Medication treatment in subjects with autistic spectrum disorders.

Authors:  J K Buitelaar; S H Willemsen-Swinkels
Journal:  Eur Child Adolesc Psychiatry       Date:  2000       Impact factor: 4.785

7.  Use of methylphenidate in the treatment of children with autistic disorder.

Authors:  H Quintana; B Birmaher; D Stedge; S Lennon; J Freed; J Bridge; L Greenhill
Journal:  J Autism Dev Disord       Date:  1995-06

8.  Comparison of long-term efficacy and safety of risperidone and haloperidol in children and adolescents with autistic disorder. An open label maintenance study.

Authors:  Ozlem Gencer; F Neslihan Inal Emiroglu; Suha Miral; Burak Baykara; Aysen Baykara; Eray Dirik
Journal:  Eur Child Adolesc Psychiatry       Date:  2008-06       Impact factor: 4.785

Review 9.  Antipsychotics in the treatment of autism.

Authors:  David J Posey; Kimberly A Stigler; Craig A Erickson; Christopher J McDougle
Journal:  J Clin Invest       Date:  2008-01       Impact factor: 14.808

10.  Aripiprazole monotherapy in children and young adolescents with pervasive developmental disorders: a retrospective study.

Authors:  Gabriele Masi; Angela Cosenza; Stefania Millepiedi; Filippo Muratori; Cinzia Pari; Francesco Salvadori
Journal:  CNS Drugs       Date:  2009       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.